Suppr超能文献

川崎病 50 年随访。

Kawasaki Disease at 50 Years.

机构信息

Division of Immunology, Program in Rheumatology, Boston Children's Hospital, Boston, Massachusetts.

出版信息

JAMA Pediatr. 2016 Nov 1;170(11):1093-1099. doi: 10.1001/jamapediatrics.2016.1446.

Abstract

IMPORTANCE

Kawasaki disease (KD) is the most recognized vasculitis of childhood. The condition's characteristic high fever, rash, mucositis, conjunctivitis, lymphadenopathy, and extremity changes are superficially unexceptional, and resolve spontaneously within a mean of 12 days. It is the acuity and the potential for life-changing damage to the coronary arteries that distinguish KD from conditions that mimic it and exemplify the unique aspects and challenges of vascular inflammation in children.

OBSERVATIONS

Although KD is an orphan disease, its role as a leading cause of acquired heart disease in children has led to significant efforts to determine its etiology, optimize diagnosis, and customize treatment according to individuals' needs. The result is that KD can now be controlled without sequelae in more than 95% of cases. Furthermore, advances in stratifying patients according to measurable risk factors allow therapy to be personalized in increasingly effective ways. High-risk patients, such as infants younger than 6 months, those with early evidence of coronary artery dilatation, and those with extreme abnormalities in laboratory test results, are often identified at presentation. This early identification allows them to be treated with corticosteroids in addition to intravenous immunoglobulin to improve their outcomes. Children with similar findings on laboratory tests and echocardiography may be treated based on algorithms for managing "incomplete KD" despite falling short of fulfilling classic diagnostic criteria. Children who do not respond to intravenous immunoglobulin are the focus of trials to minimize the duration of inflammation and thereby protect their coronary arteries in ways never before considered.

CONCLUSIONS AND RELEVANCE

Kawasaki disease is a hybrid condition at the junction of infectious diseases, immunology, rheumatology, and cardiology. Rather than being left an orphan disease, KD is bringing disciplines together to identify its genetic, pathophysiological, and hemodynamic features. In turn, this work promises to shed light on many other inflammatory conditions as well.

摘要

重要性

川崎病(KD)是儿童最常见的血管炎。该疾病的特征性高热、皮疹、黏膜炎症、结膜炎、淋巴结肿大和四肢变化表面上无明显异常,平均 12 天内可自行消退。正是这种严重性和对冠状动脉造成改变生命的潜在风险,将 KD 与模仿它的疾病区分开来,并体现了儿童血管炎症的独特方面和挑战。

观察结果

尽管 KD 是一种孤儿病,但它作为儿童获得性心脏病的主要病因,促使人们做出巨大努力来确定其病因、优化诊断,并根据个体需求定制治疗方案。结果是,现在超过 95%的病例可以控制 KD 而不遗留后遗症。此外,根据可衡量的危险因素对患者进行分层的进展,使得治疗可以以越来越有效的方式实现个性化。高危患者,如 6 个月以下的婴儿、早期有冠状动脉扩张证据的患者以及实验室检查结果有极端异常的患者,通常在就诊时就被识别出来。这种早期识别使得他们可以在静脉注射免疫球蛋白的基础上额外使用皮质类固醇来改善他们的预后。尽管不符合经典诊断标准,但具有相似实验室检查和超声心动图发现的儿童可以根据管理“不完全川崎病”的算法进行治疗。对静脉注射免疫球蛋白无反应的儿童是试验的重点,以尽量减少炎症持续时间,从而以前所未有的方式保护他们的冠状动脉。

结论和相关性

川崎病是一种混合疾病,处于传染病、免疫学、风湿病学和心脏病学的交界处。KD 并没有被遗弃为孤儿病,而是将各个学科聚集在一起,以确定其遗传、病理生理和血液动力学特征。反过来,这项工作有望为许多其他炎症性疾病提供启示。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验